Post-approval studies (Phase 4)Study completedNCT00906880
What this trial is testing
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
Who this might be right for
Human African Trypanosomiasis
Drugs for Neglected Diseases 630